Literature DB >> 33044717

Clinical implication of QFR in patients with ST-segment elevation myocardial infarction after drug-eluting stent implantation.

Jiani Tang1, Jiapeng Chu1, Hanjing Hou2, Yan Lai1, Shengxian Tu3, Fei Chen1, Yian Yao1, Zi Ye1, Yanhua Gao1, Yu Mao1, Shaowei Zhuang2, Xuebo Liu4.   

Abstract

The feasibility and prognostic value of quantitative flow ratio (QFR) after percutaneous coronary intervention (PCI) in ST-segment elevation myocardial infarction (STEMI) patients have not been assessed. The aim of this study was to investigate the prognostic utility of post-PCI QFR to predict outcomes in STEMI and determine the influence of functional results, in both culprit and nonculprit lesions, after PCI. Patients undergoing PCI of culprit lesions and receiving staged procedures of nonculprit lesions after 7 days were enrolled from 2 centers and underwent post-PCI QFR. The primary outcome was the vessel-oriented composite endpoints (VOCEs), defined as vessel-related cardiovascular death, vessel-related myocardial infarction, and target vessel revascularization. Four hundred fifteen vessels (186 culprit lesions and 219 nonculprit lesions) in 186 patients were analyzed. Measured at staged PCI, the post-PCI QFR of culprit lesions was significantly lower than that of nonculprit lesions (0.92 ± 0.10 versus 0.95 ± 0.08, p < 0.001). The multivariable model demonstrated that low post-PCI QFR was an independent predictor of 2-year VOCE (20.8% versus 5.7%; hazard ratio 2.718; 95% CI 1.347-5.486; p = 0.005). In STEMI patients with a low angiography-derived index of microcirculatory resistance (≤ 40U), a good correlation and agreement between post-PCI QFR value of culprit lesions at primary and staged procedures (r = 0.942; mean difference: - 0.0017 [- 0.074 to 0.070]) was identified. In conclusion, culprit lesions suffered from suboptimal functional results more frequently compared to nonculprit lesions after PCI in STEMI patients. Low post-PCI QFR was associated with subsequent adverse clinical outcomes. After stenting, culprit lesions may feasibly be assessed through QFR without significant microvascular dysfunction.

Entities:  

Keywords:  Percutaneous coronary intervention; Quantitative flow ratio; ST-segment elevation myocardial infarction; Vessel-oriented composite endpoint

Mesh:

Year:  2020        PMID: 33044717     DOI: 10.1007/s10554-020-02068-0

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  43 in total

1.  Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial.

Authors:  Frederik M Zimmermann; Angela Ferrara; Nils P Johnson; Lokien X van Nunen; Javier Escaned; Per Albertsson; Raimund Erbel; Victor Legrand; Hyeong-Cheol Gwon; Wouter S Remkes; Pieter R Stella; Pepijn van Schaardenburgh; G Jan Willem Bech; Bernard De Bruyne; Nico H J Pijls
Journal:  Eur Heart J       Date:  2015-09-23       Impact factor: 29.983

2.  Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes.

Authors:  Nils P Johnson; Gábor G Tóth; Dejian Lai; Hongjian Zhu; Göksel Açar; Pierfrancesco Agostoni; Yolande Appelman; Fatih Arslan; Emanuele Barbato; Shao-Liang Chen; Luigi Di Serafino; Antonio J Domínguez-Franco; Patrick Dupouy; Ali M Esen; Ozlem B Esen; Michalis Hamilos; Kohichiro Iwasaki; Lisette O Jensen; Manuel F Jiménez-Navarro; Demosthenes G Katritsis; Sinan A Kocaman; Bon-Kwon Koo; Ramón López-Palop; Jeffrey D Lorin; Louis H Miller; Olivier Muller; Chang-Wook Nam; Niels Oud; Etienne Puymirat; Johannes Rieber; Gilles Rioufol; Josep Rodés-Cabau; Steven P Sedlis; Yasuchika Takeishi; Pim A L Tonino; Eric Van Belle; Edoardo Verna; Gerald S Werner; William F Fearon; Nico H J Pijls; Bernard De Bruyne; K Lance Gould
Journal:  J Am Coll Cardiol       Date:  2014-10-21       Impact factor: 24.094

3.  Prognostic Value of Fractional Flow Reserve Measured Immediately After Drug-Eluting Stent Implantation.

Authors:  Zsolt Piroth; Gabor G Toth; Pim A L Tonino; Emanuele Barbato; Soheila Aghlmandi; Nick Curzen; Gilles Rioufol; Nico H J Pijls; William F Fearon; Peter Jüni; Bernard De Bruyne
Journal:  Circ Cardiovasc Interv       Date:  2017-08       Impact factor: 6.546

4.  2018 ESC/EACTS Guidelines on myocardial revascularization.

Authors:  Franz-Josef Neumann; Miguel Sousa-Uva; Anders Ahlsson; Fernando Alfonso; Adrian P Banning; Umberto Benedetto; Robert A Byrne; Jean-Philippe Collet; Volkmar Falk; Stuart J Head; Peter Jüni; Adnan Kastrati; Akos Koller; Steen D Kristensen; Josef Niebauer; Dimitrios J Richter; Petar M Seferovic; Dirk Sibbing; Giulio G Stefanini; Stephan Windecker; Rashmi Yadav; Michael O Zembala
Journal:  Eur Heart J       Date:  2019-01-07       Impact factor: 29.983

5.  Short- and long-term cause of death in patients treated with primary PCI for STEMI.

Authors:  Frants Pedersen; Vitalij Butrymovich; Henning Kelbæk; Kristian Wachtell; Steffen Helqvist; Jens Kastrup; Lene Holmvang; Peter Clemmensen; Thomas Engstrøm; Peer Grande; Kari Saunamäki; Erik Jørgensen
Journal:  J Am Coll Cardiol       Date:  2014-11-10       Impact factor: 24.094

6.  Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries.

Authors:  David Brieger; Stuart J Pocock; Stefan Blankenberg; Ji Yan Chen; Mauricio G Cohen; Christopher B Granger; Richard Grieve; Jose C Nicolau; Tabassome Simon; Dirk Westermann; Satoshi Yasuda; John Gregson; Kirsten L Rennie; Katarina Hedman; Karolina Andersson Sundell; Shaun G Goodman
Journal:  Int J Cardiol       Date:  2020-01-28       Impact factor: 4.164

7.  Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.

Authors:  Bernard De Bruyne; Nico H J Pijls; Bindu Kalesan; Emanuele Barbato; Pim A L Tonino; Zsolt Piroth; Nikola Jagic; Sven Möbius-Winkler; Sven Mobius-Winckler; Gilles Rioufol; Nils Witt; Petr Kala; Philip MacCarthy; Thomas Engström; Keith G Oldroyd; Kreton Mavromatis; Ganesh Manoharan; Peter Verlee; Ole Frobert; Nick Curzen; Jane B Johnson; Peter Jüni; William F Fearon
Journal:  N Engl J Med       Date:  2012-08-27       Impact factor: 91.245

8.  Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.

Authors:  Paul Sorajja; Bernard J Gersh; David A Cox; Michael G McLaughlin; Peter Zimetbaum; Costantino Costantini; Thomas Stuckey; James E Tcheng; Roxana Mehran; Alexandra J Lansky; Cindy L Grines; Gregg W Stone
Journal:  Eur Heart J       Date:  2007-06-07       Impact factor: 29.983

9.  Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial.

Authors:  Manel Sabaté; Salvatore Brugaletta; Angel Cequier; Andrés Iñiguez; Antonio Serra; Pilar Jiménez-Quevedo; Vicente Mainar; Gianluca Campo; Maurizio Tespili; Peter den Heijer; Armando Bethencourt; Nicolás Vazquez; Gerrit Anne van Es; Bianca Backx; Marco Valgimigli; Patrick W Serruys
Journal:  Lancet       Date:  2015-10-29       Impact factor: 79.321

10.  Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data.

Authors:  Frederik M Zimmermann; Elmir Omerovic; Stephane Fournier; Henning Kelbæk; Nils P Johnson; Martina Rothenbühler; Panagiotis Xaplanteris; Mohamed Abdel-Wahab; Emanuele Barbato; Dan Eik Høfsten; Pim A L Tonino; Bianca M Boxma-de Klerk; William F Fearon; Lars Køber; Pieter C Smits; Bernard De Bruyne; Nico H J Pijls; Peter Jüni; Thomas Engstrøm
Journal:  Eur Heart J       Date:  2019-01-07       Impact factor: 29.983

View more
  4 in total

1.  Association of quantitative flow ratio-derived microcirculatory indices with anatomical-functional discordance in intermediate coronary lesions.

Authors:  Liang Geng; Yuan Yuan; Peizhao Du; Liming Gao; Yunkai Wang; Jiming Li; Wei Guo; Ying Huang; Qi Zhang
Journal:  Int J Cardiovasc Imaging       Date:  2021-05-31       Impact factor: 2.357

2.  Impact of diabetes on coronary physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention.

Authors:  Zhen Ye; Qin Chen; Jiaxin Zhong; Long Chen; Lihua Chen; Mingfang Ye; Yuanming Yan; Lianglong Chen; Yukun Luo
Journal:  J Diabetes Investig       Date:  2022-03-29       Impact factor: 3.681

3.  Clinical implication of quantitative flow ratio to predict clinical events after drug-coated balloon angioplasty in patients with in-stent restenosis.

Authors:  Jiani Tang; Hanjing Hou; Jiapeng Chu; Fei Chen; Yian Yao; Yanhua Gao; Zi Ye; Shaowei Zhuang; Yan Lai; Xuebo Liu
Journal:  Clin Cardiol       Date:  2021-05-19       Impact factor: 2.882

4.  Functional Assessment of Cerebral Artery Stenosis by Angiography-Based Quantitative Flow Ratio: A Pilot Study.

Authors:  Kangmo Huang; Weihe Yao; Juan Du; Fang Wang; Yunfei Han; Yunxiao Chang; Rui Liu; Ruidong Ye; Wusheng Zhu; Shengxian Tu; Xinfeng Liu
Journal:  Front Aging Neurosci       Date:  2022-02-01       Impact factor: 5.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.